magnesium sulfate has been researched along with Brain Hemorrhage in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Avgerinos, KI; Chatzisotiriou, A; Haidich, AB; Lioutas, VA; Tsapas, A | 1 |
Conwit, R; Eckstein, M; Goldweber, R; Hamilton, S; Kramer, I; Liebeskind, DS; Moreau, G; Pratt, FD; Sanossian, N; Saver, JL; Starkman, S; Stratton, SJ; Sung, G | 1 |
Barkovich, AJ; Ferriero, DM; Gano, D; Glass, HC; Ho, ML; Partridge, JC; Xu, D | 1 |
Gomibuchi, H; Hara, T; Kakogawa, J; Kimura, A; Masuya, N; Minoura, S; Oda, H; Ohno, H; Sadatsuki, M | 1 |
Bragetti, P; Burnelli, L; Clerici, G; Della Torre, B; Di Renzo, GC; Fantauzzi, A; Gerli, S; Lungarotti, MS; Luzi, G; Marinelli, D; Mezzetti, D; Mignosa, M; Taddei, F | 1 |
Haddad, B; Hays, SP; Rouzier, R | 1 |
Mittendorf, R; Pyrde, PG | 1 |
Bental, Y; Davkin, O; Lusky, A; Reichman, B; Rotschild, A; Solovechick, M; Waisman, D; Weintraub, Z | 1 |
1 review(s) available for magnesium sulfate and Brain Hemorrhage
Article | Year |
---|---|
Intravenous Magnesium Sulfate in Acute Stroke.
Topics: Administration, Intravenous; Brain Ischemia; Humans; Intracranial Hemorrhages; Magnesium Sulfate; Neuroprotective Agents; Stroke; Survival Rate; Treatment Outcome | 2019 |
1 trial(s) available for magnesium sulfate and Brain Hemorrhage
Article | Year |
---|---|
Prehospital use of magnesium sulfate as neuroprotection in acute stroke.
Topics: Acute Disease; Aged; Brain Ischemia; Double-Blind Method; Emergency Medical Services; Female; Hemorrhage; Humans; Infusions, Intravenous; Intracranial Hemorrhages; Magnesium Sulfate; Male; Middle Aged; Neuroprotective Agents; Stroke; Time-to-Treatment | 2015 |
6 other study(ies) available for magnesium sulfate and Brain Hemorrhage
Article | Year |
---|---|
Antenatal Exposure to Magnesium Sulfate Is Associated with Reduced Cerebellar Hemorrhage in Preterm Newborns.
Topics: Cohort Studies; Cross-Sectional Studies; Female; Humans; Infant, Newborn; Infant, Premature; Intracranial Hemorrhages; Magnesium Sulfate; Magnetic Resonance Imaging; Male; Neuroprotective Agents; Pregnancy; Prospective Studies | 2016 |
Antepartum intracranial hemorrhage due to unrecognized unilateral moyamoya disease: a case report.
Topics: Adult; Alanine Transaminase; Anticonvulsants; Antihypertensive Agents; Aspartate Aminotransferases; Cesarean Section; Emergencies; Female; Headache; HELLP Syndrome; Hemiplegia; Humans; Infant, Newborn; Infarction, Middle Cerebral Artery; Intracranial Hemorrhages; L-Lactate Dehydrogenase; Magnesium Sulfate; Male; Moyamoya Disease; Platelet Transfusion; Pregnancy; Puerperal Disorders; Tomography, X-Ray Computed; Unconsciousness | 2011 |
The combined maternal administration of magnesium sulfate and aminophylline reduces intraventricular hemorrhage in very preterm neonates.
Topics: Aminophylline; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Infant, Premature; Intracranial Hemorrhages; Magnesium Sulfate; Male; Neuroprotective Agents; Pregnancy; Prospective Studies | 2005 |
The benefit of combined maternal administration of magnesium sulfate and aminophylline.
Topics: Aminophylline; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Infant, Premature; Intracranial Hemorrhages; Magnesium Sulfate; Neuroprotective Agents; Pregnancy | 2006 |
Neuroprophylaxis with aminophylline and magnesium sulfate?
Topics: Aminophylline; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Infant, Premature; Intracranial Hemorrhages; Magnesium Sulfate; Neuroprotective Agents; Pregnancy | 2006 |
Effect of maternal tocolysis on the incidence of severe periventricular/intraventricular haemorrhage in very low birthweight infants.
Topics: Anti-Inflammatory Agents; Apgar Score; Ductus Arteriosus, Patent; Female; Gestational Age; Humans; Indomethacin; Infant, Newborn; Infant, Very Low Birth Weight; Intracranial Hemorrhages; Logistic Models; Magnesium Sulfate; Multivariate Analysis; Pneumothorax; Pregnancy; Prenatal Exposure Delayed Effects; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Risk Factors; Ritodrine; Steroids; Tocolytic Agents | 2001 |